This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n4http://linked.opendata.cz/resource/drugbank/drug/DB04733/identifier/pdb/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04733/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04733/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04733/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04733
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n8:DB04733 n10:DB04733
dcterms:title
1,6-DI-O-PHOSPHONO-D-MANNITOL
adms:identifier
n4:M2P n11:4369446 n12:46508477 n13:DB04733
n5:IUPAC-Name
n6:271B4E23-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4E29-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4E28-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4E25-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4E26-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4E27-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4E21-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4E1F-363D-11E5-9242-09173F13E4C5 n6:271B4E22-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4E20-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4E2F-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4E30-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4E2A-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4E2B-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4E2D-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4E2C-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4E2E-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4E35-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4E37-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4E38-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4E34-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4E33-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4E36-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4E24-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4E31-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4E32-363D-11E5-9242-09173F13E4C5